News
05-16-2014, 05:11 AM
Provectus Biopharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that its shares will begin trading on the NYSE MKT today, Friday, May 16, 2014.
More... (http://www.news-medical.net/news/20140516/Provectuse28099-shares-to-begin-trading-on-NYSE-MKT-on-May-16-2014.aspx)
More... (http://www.news-medical.net/news/20140516/Provectuse28099-shares-to-begin-trading-on-NYSE-MKT-on-May-16-2014.aspx)